Skip to content
We Love European Products
Doliprane 500 mg sachets-dose
Doliprane 500 mg sachets-dose - Sanofi with score 50/100

Doliprane 500 mg sachets-dose - European Score 50/100

Sanofi

Doliprane 500 mg sachets-dose by Sanofi is rated 50/100 according to our European origin criteria. Average choice. It has some European connections but could be better.

It is a product product found in 1 countries.

12

3400932331536

Nutritional Scores

Nutri-Score
NOT-APPLICABLE
Eco-Score
UNKNOWN

Categories

incorrect product type Non food products health beauty health care medical products medicine medicine drugs non open products facts open beauty facts

Ingredients

.500 mg pour un sa Composition. Paracétamol Excipient à effet notoire : saccharose. Voir la notice pour plus d'informations. Indications d'utilisation. Attention : ce médicament paracétamol. D'autres médicaments en contiennent. Ne les afin de ne pas dépasser la dose quotidienne recommandée. en cas de douleurs et/ou fièvre telles que maux de tête, é douleurs dentaires, courbatures, règles douloureuses. Cette présentation est réservée à l'adulte et à l'enfant à (à partir d'environ 8 ans) lire attentivement la notice, rubric Pour les enfants ayant un poids inférieur à 27 kg, il présentations de paracétamol. Demandez conseil à vc votre pharmacien.

Origin Data

Countries france
Packaging sachets-dose pour solution buvable

European Score

0 /100
Distant Relative

"It has a cousin in Europe, but they haven't spoken in years."

Detailed Breakdown:

Scoring Methodology
Headquarters 35/35
Manufacturing 0/35
Ingredients 0/10
Distribution 15/15

Analysis:

  • Corporate headquarters in France & Monaco (+35 pts)
  • Manufacturing location unknown
  • Ingredients not specified
  • Distributed exclusively in Europe (1 countries) (+15 pts)
Amazon logo
Buy on Amazon

Affiliate link. Independent from score results.

Analysis & Insights

Expert Data Analysis

The European Score of 50/100 for Doliprane 500 mg sachets-dose suggests a moderate alignment with regional economic standards.

When analyzing the corporate structure of Sanofi, we see its direct and positive impact on the regional economy.

Data confirms that this product fails to meet basic regional ecological expectations.

The lack of transparent health data for this product is a significant concern for the European consumer.

Transparency from Sanofi on this reference is acceptable but lacks granular sourcing details.

This is a typical market choice, offering some European ties without absolute excellence.

Looking for better alternatives...